Franklin.ai Market Research Report

Company Overview

• Name: Franklin.ai

• Mission: To improve diagnostic accuracy and increase workflow efficiency in pathology using AI technology. The mission is to raise the standard of healthcare and help pathologists diagnose with confidence and report faster.

• Founded: 2022

• Founders: Dr. Aengus Tran and Dimitry Tran

• Key People:

• Stephen Ruffels: Chief Executive Officer

• Ben Johnston: Principal Engineer

• Raj Bhuva: Head of IT

• Eric Qin: Head of Global Regulatory & Quality

• Harriet Kilpatrick: Senior Product Manager

• Jennifer Mulheron: General Counsel

• Thuy Thai: Chief Financial Officer

• Phillip Young: Engineering Manager

• Nic Carr: Chief Product Officer

• Headquarters: Gadigal Country, Eora Nation, Australia

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Franklin.ai is known for developing advanced AI tools for pathology which aid in diagnosing prostate-related specimens and supporting pathologists worldwide.

Products

Franklin.ai Digital

• Description: An advanced AI-powered software focused on detecting clinical findings in Prostate Core Biopsy (PCB) and Transurethral Resection of the Prostate (TURP) specimens.

• Key Features:

• Detects 45 clinical findings with high agreement with prostate specialists.

• Workflow efficiency through pre-analysis of cases and pre-filled synoptic reports.

• Includes segmentation, quantification, and integration capabilities with various laboratory systems (LIS, IMS, WSIV, Scanner).

• Available as both cloud and on-premises solutions.

Franklin.ai Glass

• Description: AI solution that provides support without requiring a digital scanner by utilizing glass slides.

• Key Features:

• Offers AI feedback for prostate core biopsies.

• Facilitates multidisciplinary team meetings, research, and teaching with high-quality image sharing.

• Acts as a standalone solution requiring no integration.

Recent Developments

• Recent Partnerships: Franklin.ai has partnered with Sonic Healthcare, a global medical diagnostics leader, to augment expertise and enhance product development.

• New Product Launches: Currently, the key products are Franklin.ai Digital and Franklin.ai Glass focusing on prostate tissue support. Expansion into other tissue types is planned.

• New Features Added: The platform has integrated a broad ontology covering 45+ malignant and benign findings and supports automated quantification for efficiency.

• Strategic Collaborations: Collaborated with Harrison.ai for accelerating AI technology deployment in pathology.

Summary

Franklin.ai has positioned itself as a transformative player in the field of digital pathology via its advanced AI solutions designed to enhance diagnostic accuracy and improve the workflow efficiencies of pathologists globally. By leveraging their strategic partnerships and focusing on comprehensive products such as Franklin.ai Digital and Glass, the company aims to address the challenges posed by increasing pathology workloads and improve healthcare standards worldwide.